文献速递主动脉疾病

单中心评估医师改良开窗或平行支架移植物治疗复杂主动脉疾病

Monocentric Evaluation of Physician-Modified Fenestrations or Parallel Endografts for Complex Aortic Diseases.
PubMed 文献 · J Endovasc Ther · 2023-01-16

该单中心回顾性研究纳入2013至2021年67例连续接受开窗或平行技术腔内修复的复杂主动脉疾病患者,比较f-EVAR与ch-EVAR的围术期及随访结果。f-EVAR和ch-EVAR围术期及随访结果可接受,两者短期不良事件无显著差异,联合技术组输血率更高、手术时间更长、住院更久且内漏和支架闭塞更多。

要点

  • f-EVAR主要用于累及内脏分支的AAA和TAAA,ch-EVAR通常用于肾下AAA。
  • f-EVAR、ch-EVAR和联合组平均重建动脉数分别为2.3±0.9、1.4±0.6、3.5±0.5(p<0.001)。
  • f-EVAR与ch-EVAR除手术时间外,输血、ICU或住院时间、肌酐、30天及随访并发症无显著差异。

核心结论

  • f-EVAR和ch-EVAR技术具有可接受的围术期和随访结果,在遇到复杂主动脉疾病时应被视为可行的替代方案。

研究设计与样本

  • 单中心回顾性研究纳入2013至2021年67例连续接受f-EVAR或ch-EVAR治疗的复杂主动脉疾病患者,疾病包括腹主动脉瘤、胸腹主动脉瘤、主动脉夹层或既往腔内修复。

主要发现

  • 34例接受f-EVAR、27例接受ch-EVAR、6例接受两者联合。
  • f-EVAR、ch-EVAR和联合组平均重建动脉数分别为2.3±0.9、1.4±0.6、3.5±0.5(p<0.001)。
  • f-EVAR、ch-EVAR和联合组初次技术成功率分别为28例(82.4%)、22例(81.5%)和3例(50.0%)。
  • f-EVAR与ch-EVAR组间除手术时间(5.77±2.58 vs 4.47±1.44,p=0.033)外,输血、ICU或住院时间、血肌酐水平、30天并发症或随访并发症均无显著差异。
  • 联合技术组输血率更高(p=0.044)、手术时间更长(p=0.008)、住院时间更长(p=0.017),短期支架闭塞(p=0.001)和内漏(p=0.004)更多,中期随访内漏率更高(p=0.023)。

临床怎么用

  • 作者认为f-EVAR和ch-EVAR技术具有可接受的围术期和随访结果,在遇到复杂主动脉疾病时应被视为可行的替代方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to investigate the demographic and anatomic characteristics, as well as perioperative and follow-up results of fenestration and parallel techniques for the endovascular repair of complex aortic diseases. MATERIALS AND METHODS: A retrospective study was conducted on 67 consecutive patients underwent endovascular treatment for complex aortic diseases including abdominal aortic aneurysm (AAA), thoracoabdominal aneurysm (TAAA), aortic dissection, or prior endovascular repair with either fenestrated and parallel endovascular aortic repair (f-EVAR or ch-EVAR) at a single institute from 2013 to 2021. Choices of intervention were made by the disease' emergency, patients' general condition, the anatomic characteristics, as well as following the recommendation from the devices' guidelines. Patients' clinical demographics, aortic disease characteristics, perioperative details, and disease courses were discussed. Short- and mid-term follow-up results were obtained and analyzed. Endpoints were aneurysm-related and unrelated mortality, branch instability, and renal function deterioration. RESULTS: Totally, 34 and 27 patients received f-EVAR and ch-EVAR, while 6 patients received a combination of both. Fenestrated endovascular aortic repair was conducted mainly in AAA affecting visceral branches and TAAA, whereas ch-EVAR was normally utilized for infrarenal AAA. Regarding the average number of reconstructed arteries per patient, there was a significant difference among f-EVAR, ch-EVAR, and the combination group (mean = 2.3 ± 0.9, 1.4 ± 0.6, 3.5 ± 0.5, p<0.001). Primary technical success was achieved in 28 (82.4%), 22 (81.5%), and 3 (50.0%) patients for each group. Besides operational time (5.77 ± 2.58, 4.47 ± 1.44, p=0.033), no significant difference was observed for blood transfusion, intensive care unit (ICU) or hospital stay, blood creatinine level, 30-day complications, or follow-up complications between patients undergoing f-EVAR or ch-EVAR. Patients receiving combination of both techniques had a higher rate of blood transfusion (p=0.044), longer operational time (p=0.008) or hospital stay (p=0.017), as well as more stent occlusion (p=0.001), endoleak (p=0.004) at short-term and a higher rate of endoleak (p=0.023) at mid-term follow-up. CONCLUSION: In conclusion, this study demonstrated that f-EVAR and ch-EVAR techniques had acceptable perioperative and follow-up results and should be considered viable alternatives when encountering complex aortic diseases. CLINICAL IMPACT: This study sought to investigate the baseline and pathological characteristics, as well as perioperative and follow-up results of f-EVAR and ch-EVAR at a single Chinese institution. F-EVAR (mostly physician-modified f-EVAR) was applied in patients with a wide range of etiologies and disease types, while ch-EVAR was preferred for AAA in older patients with an average higher ASA grade. Our experience suggested acceptable safety and efficacy both for techniques, and no significant difference was observed between the two groups regarding any short or mid-term adverse events.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Li S, Wang W, Sun X, et al. Monocentric Evaluation of Physician-Modified Fenestrations or Parallel Endografts for Complex Aortic Diseases. J Endovasc Ther. 2023. PMID: 36647195. doi:10.1177/15266028221149918

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。